News
Hanger Ivan R. Sabel Foundation to Receive $75,000 Donation Towards Charitable Prosthetic Efforts in Haiti from Grapes for Humanity/US
July 12, 2010 11:37 am | by Bio-Medicine.Org | CommentsBETHESDA, Md. , July 12 /- The Hanger Ivan R. Sabel Foundation today announced it will receive a generous donation of $75,000 from Grapes for Humanity/US, an internationally recognized charitable foundation that has raised millions of dollars in support of landmine survivors and innocent...
DocNog California Mobile App Automates Medical Provider Search
July 12, 2010 11:37 am | by Bio-Medicine.Org | CommentsMURRIETA, Calif. , July 12 /- NogWorld LLC, a pioneer in mobile search technology, has launched DocNog, a mobile app designed to empower healthcare consumers to easily connect and access medical providers. The DocNog California App was recently featured in the "New and Noteworthy" section...
Holon: The Process Adaptive Interoperability Framework
July 12, 2010 11:37 am | by Bio-Medicine.Org | CommentsATLANTA , July 12 /- Holon, the new standard for healthcare interoperability, today announced general availability of its Medication Management solution. Leveraging the Holon Process Adaptive Interoperability Framework, Holon introduces a cost-effective alternative to your paper processes...
Early diagnosis key in managing, treating bladder cancer
July 12, 2010 11:36 am | by Baylor College of Medicine | CommentsEarly diagnosis of bladder cancer is critical to management and treatment of the disease and improving chances of survival, said a urologic oncologist from Baylor College of Medicine . "Bladder cancer is a highly treatable, highly curable disease particularly before it invades the...
BCM researchers leading efforts in bladder cancer research
July 12, 2010 11:36 am | by Baylor College of Medicine | CommentsResearchers from Baylor College of Medicine's Scott Department of Urology , Department of Molecular and Cellular Biology and the NCI-designated Dan L. Duncan Cancer Center are leading major efforts in bladder cancer research, both in the clinical and lab setting. Find out more about...
Older men with smoking history needed for bladder cancer screening study
July 12, 2010 11:36 am | by Baylor College of Medicine | CommentsMen over the age of 60 who have smoked for at least 20 years are being asked to participate in a bladder cancer screening study at Baylor College of Medicine . Currently, there is no established screening method for bladder cancer. "We want to find a way to detect the cancer early enough...
Telik Announces Publication of Review Focused on the Inhibition of the Enzyme GSTP1-1 as a Target for New Cancer Treatments
July 12, 2010 11:36 am | by Bio-Medicine.Org | CommentsPALO ALTO, Calif. , July 12 /- Telik, Inc. (Nasdaq: TELK ) today announced the publication of a review in the journal, Cell Death and Differentiation : Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death;...
Novelos revives failed drug as potential breast cancer treatment
July 12, 2010 11:34 am | by Mass High Tech: The Journal of New England Technology | CommentsNovelos Therapeutics Inc. has announced positive Phase 2 results for NOV-002 to treat patients with certain types of breast cancer, following an earlier failure of the drug target to treat lung cancer.
Lantheus Medical acquires global rights to ex-Epix product
July 12, 2010 11:34 am | by Mass High Tech: The Journal of New England Technology | CommentsDiagnostic imaging firm Lantheus Medical Imaging Inc. has acquired global rights to Ablavar, a blood pool imaging agent used in patients with peripheral vascular disease and formerly owned by now-bankrupt Epix Pharmaceuticals Inc.
Supreme Court Decision Could Help Protect Patents for Diagnostics
July 12, 2010 8:31 am | by U.S. Food & Drug Administration | CommentsDiagnostic companies seeking to patent a process or method used in product development may have an easier time doing so following a recent Supreme Court decision.
Industry: The FDA Can Do More to Speed Development of HDEs
July 12, 2010 8:31 am | by U.S. Food & Drug Administration | CommentsDevicemakers are asking for more incentives and flexible standards as the FDA explores ways to encourage the development of devices to treat rare diseases.
Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
July 12, 2010 7:35 am | by Bio-Medicine.Org | CommentsSAN DIEGO , PARSIPPANY, N.J. and INDIANAPOLIS , July 12 /- Accumetrics, Inc., Daiichi Sankyo, Inc, and Eli Lilly and Company announced today that the companies have entered into a strategic collaboration in the United States to raise awareness about antiplatelet therapy and the role of...
Visterra takes in $6M VC funds, launches Singapore arm
July 12, 2010 7:34 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge biotech startup Visterra Inc., formerly known as Parasol Therapeutics, has landed $6 million in its first round of funding, which accompanied the launch of Visterra Singapore Pte. Ltd. from Visterra, the Singapore-MIT Alliance for Research and Technology (SMART) Center and the...
MedPro Imaging to Supply Mobile Ultrasound Diagnostics to Chicago Bears Players
July 12, 2010 7:34 am | by Bio-Medicine.Org | CommentsWAUKESHA, Wis. , July 12 /- MedPro Imaging, a leading supplier of new and refurbished ultrasound solutions, announced the company has been chosen by the Chicago Bears Football Club, Inc. to supply mobile ultrasound services for helping to diagnose injuries and other health issues for the...
Ethicon Endo-Surgery Completes Divestiture of Breast Care Business to Devicor Medical Products
July 12, 2010 7:34 am | by Bio-Medicine.Org | CommentsCINCINNATI , July 12 /- Ethicon Endo-Surgery, Inc. (EES), a Johnson & Johnson company, today announced it has completed the divestiture of its Breast Care business to Devicor Medical Products, Inc., a portfolio company of GTCR. Financial terms of the transaction are not being...
